These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6218653)

  • 1. Variable MLC stimulatory capacity of neoplastic B and non-B/non-T lymphocytes expressing HLA-DR antigens.
    Bom-van Noorloos AA; Schreuder I; de Groot-Swings G; Ubels-Postma J; von dem Borne AE; Melief CJ
    Tissue Antigens; 1982 Nov; 20(5):352-63. PubMed ID: 6218653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the alloactivated E+Ia+ cell capable of stimulating in mixed lymphocyte culture.
    Shen HH; Irigoyen O; Friedman SM; Chess L
    J Immunol; 1982 Jan; 128(1):501-5. PubMed ID: 6459379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class II specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset.
    Jaraquemada D; Navarrete C; Ollier W; Awad J; Okoye R; Festenstein H
    Hum Immunol; 1986 Jul; 16(3):259-70. PubMed ID: 2424875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heated lymphocytes express HLA-DR antigens despite their inability to stimulate in MLC.
    Brewer JA; Hank JA; Wendel T; Schmeling GJ; Blank JL; Morrissey LW; Robins HI; Sondel PM
    Tissue Antigens; 1983 Oct; 22(4):246-56. PubMed ID: 6228035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation by CLL cells in mixed lymphocyte culture (MLC).
    Jones EH; Hockley AB; Lawler SD
    Br J Cancer; 1981 Nov; 44(5):675-81. PubMed ID: 6172142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and expression of the HLA-DC antigens defined by anti-Leu 10.
    Chen YX; Evans RL; Pollack MS; Lanier LL; Phillips JH; Rousso C; Warner NL; Brodsky FM
    Hum Immunol; 1984 Aug; 10(4):221-35. PubMed ID: 6332101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of shared lymphocyte-stimulating determinants between H-2I and HLA-D/DR using mouse primed lymphocyte typing cells.
    Shaut DM; Ireland J; Scornik JC; Peck AB
    Hum Immunol; 1983 Jun; 7(2):105-15. PubMed ID: 6190790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The active rosette mixed-lymphocyte reaction: an early marker of lymphocyte activation linked to HLA-D-DR differences.
    Wybran J; Dupont E
    Clin Immunol Immunopathol; 1983 Apr; 27(1):51-5. PubMed ID: 6223752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.
    Guerry D; Alexander MA; Herlyn MF; Zehngebot LM; Mitchell KF; Zmijewski CM; Lusk EJ
    J Clin Invest; 1984 Jan; 73(1):267-71. PubMed ID: 6606651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses.
    Taylor GM; Fergusson W; Dyer PA; Harris R; Morrell G
    Cancer Immunol Immunother; 1983; 16(2):117-22. PubMed ID: 6229327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B lymphocyte function in B cell chronic lymphocytic leukaemia.
    Wolos JA; Davey FR
    Br J Haematol; 1981 Nov; 49(3):395-403. PubMed ID: 6457623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation and expression of HLA-DR alpha.
    Reitz MS; Mann DL; Eiden M; Trainor CD; Clarke MF
    Mol Cell Biol; 1984 May; 4(5):890-7. PubMed ID: 6328275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunodiagnosis of chronic lymphatic leukemia and leukemic non-Hodgkin's lymphoma with the monoclonal antibodies BL-Ig-L/1, BL-DR/1 and BL-T2].
    Malberg K; Fischer H; Elendt D; Wutke K; Fiebig H
    Arch Geschwulstforsch; 1984; 54(4):325-32. PubMed ID: 6437368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens.
    Halper JP; Fu SM; Gottlieb AB; Winchester RJ; Kunkel HG
    J Clin Invest; 1979 Nov; 64(5):1141-8. PubMed ID: 159311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface markers on leukemia and lymphoma cells: recent advances.
    Foon KA; Schroff RW; Gale RP
    Blood; 1982 Jul; 60(1):1-19. PubMed ID: 6805534
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the stimulating capacity of human leukemia T-cell, null cell, and B-cell lines in mixed lymphoma culture.
    Tsubota T; Miyoshi I; Uno J; Hiraki S; Kimura I
    J Natl Cancer Inst; 1978 Apr; 60(4):793-5. PubMed ID: 147348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in accessory cell requirements in human mixed lymphocyte response to leukaemic cell lines.
    O'Keefe D; Ashman L
    Immunology; 1982 Dec; 47(4):633-41. PubMed ID: 6216200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.
    Broxmeyer HE; Juliano L; Lu L; Platzer E; Dupont B
    J Clin Invest; 1984 Apr; 73(4):939-53. PubMed ID: 6231314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.